Ballicules.com

Sugammadex

BRIDION

Pronunciation: soo-GAM-ma-dex

Sugammadex ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Sugammadex ballicule
Sugammadex BRIDION mascot mnemonic cartoon
Visual mnemonic: Sugammadex mascot
“Mad sugar”
molecular cage” encapsulates the rocuronium molecule within a lipophilic core

What it isModified gamma-cyclodextrin that encapsulates rocuronium and vecuronium; reversal of neuromuscular blockade.

Why this oneIt reverses even profound blockade within minutes, which neostigmine cannot, and needs no antimuscarinic cover.

What limits itIt binds hormonal contraceptives, so a week of alternative contraception is required. Bradycardia; it does not reverse succinylcholine.

Sugammadex molecular structure (skeletal formula)
Molecular structure: Sugammadex

FDA label

FDA dosingPopulationStartTargetMax
Reversal of rocuronium/vecuronium block — deep (1-2 PTC, no TOF twitches)Adults, single IV bolus4 mg/kg4 mg/kg
Reversal of rocuronium/vecuronium block — moderate (2nd TOF twitch reappeared)Adults, single IV bolus2 mg/kg2 mg/kg
Immediate reversal (~3 min after 1.2 mg/kg rocuronium; rocuronium only)Adults, single IV bolus16 mg/kg16 mg/kg

Renal Not recommended in severe renal impairment (CrCl <30 mL/min), including patients on dialysis.

Hepatic Undefined

Waiting time to re-administer an NMBA depends on sugammadex dose and renal function; consider a nonsteroidal NMBA.

Instructions

Available strengths

Cautions

Adverse reactions

Pregnancy Insufficient human data; animal studies showed reduced fetal weight/ossification at high (maternally toxic) doses.

Lactation Undefined

Cost

Sugammadex (BRIDION)
Strength#/mogeneric $/unitCostPlus
100 mg/mLinjper unitnot offered
NADAC is a voluntary CMS survey of what retail community pharmacies pay for the drugs they stock. Sugammadex is administered under clinical supervision and dispensed outside retail pharmacies, so it rarely appears on surveyed invoices.

NO BOXED WARNINGS

Principal riskIt binds hormonal contraceptives for a week

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger2 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryN/A (post-2015 labeling)

Defining liabilityAnaphylaxis and abrupt bradycardia or cardiac arrest

Open Sugammadex in the interactive console ↗